TriMas Corporation 2012 Q3 Form 10-Q Summary
Business Context and Reporting Period
TriMas is a global manufacturer and distributor serving commercial, industrial and consumer markets through Packaging, Energy, Aerospace & Defense, Engineered Components, Cequent Asia Pacific and Cequent Americas. This unaudited Form 10-Q covers the three and nine months ended September 30, 2012, compared with the corresponding 2011 periods.
Financial Performance and Position
| Metric | Q3 2012 | Q3 2011 | 9M 2012 | 9M 2011 |
|---|---|---|---|---|
| Net sales | $335.9 million | $277.7 million | $971.9 million | $824.3 million |
| Gross profit / margin | $90.1 million / 26.8% | $81.9 million / 29.5% | $264.9 million / 27.3% | $242.1 million / 29.4% |
| Operating profit / margin | $36.6 million / 10.9% | $35.8 million / 12.9% | $108.5 million / 11.2% | $104.9 million / 12.7% |
| Net income attributable to TriMas | $18.7 million | $18.3 million | $47.8 million | $47.1 million |
| Diluted EPS | $0.47 | $0.52 | $1.28 | $1.36 |
| Cash flow from operations | Not presented quarterly | Not presented quarterly | $15.4 million | $35.6 million |
Q3 sales rose 21.0%, while nine-month sales rose 17.9%. Q3 income from continuing operations increased to $20.0 million from $17.0 million; nine-month income from continuing operations increased to $49.4 million from $43.7 million. The 2011 discontinued operations contributed $1.3 million in Q3 and $3.4 million in the first nine months; there were no discontinued-operation results in 2012.
- Cash and equivalents were $26.1 million at September 30, 2012, down from $88.9 million at December 31, 2011.
- Total debt was $430.0 million, including $18.0 million of current maturities, compared with $469.9 million at year-end 2011. Long-term debt was $412.0 million.
- Total assets increased to $1.145 billion from $986.5 million, primarily reflecting acquisitions, goodwill and intangible assets.
- Receivables increased to $185.0 million and inventories to $220.5 million from $135.6 million and $178.0 million, respectively, at December 31, 2011.
- Net cash used in investing activities was $118.1 million, including $84.6 million for acquisitions and $36.4 million of capital expenditures.
- Net cash provided by financing activities was $39.9 million, including $79.0 million of net equity-offering proceeds, partly offset by the $50.0 million senior-note repurchase and related costs.
Material Changes Versus the Prior Comparable Period
- Sales increased in all six segments during Q3. Nine-month sales increased in all segments except Aerospace & Defense.
- Packaging benefited substantially from the Arminak acquisition and prior-year Innovative Molding acquisition. Q3 Packaging sales increased 67.6% to $77.2 million; operating profit increased to $18.2 million from $10.2 million.
- Q3 Energy sales increased 6.5%, but operating profit declined to $3.8 million from $4.6 million because of acquisition costs, lower-margin new branches and market-entry pricing.
- Aerospace & Defense Q3 sales increased 2.4% and operating profit increased to $6.0 million from $5.4 million, supported by higher-margin aerospace sales.
- Engineered Components sales increased 12.8%, but operating profit declined to $6.3 million from $7.7 million because of product mix and lower fixed-cost absorption in the engine business.
- Cequent Asia Pacific sales increased 44.0%, while operating profit declined to $4.0 million from $5.3 million due to facility consolidation inefficiencies, duplicate costs, acquisition accounting adjustments and lower-margin acquired businesses.
- Cequent Americas sales increased 6.7%, but operating profit declined to $8.4 million from $9.6 million because of footprint-expansion costs, higher SG&A and unfavorable mix.
- Company gross margin declined 270 basis points in Q3 and 210 basis points for the first nine months. Management cited acquisition-related purchase accounting, lower-margin acquired businesses, facility relocations, growth investments, product mix and currency effects.
- Interest expense declined to $9.5 million in Q3 and $30.4 million for the nine months, from $10.7 million and $34.4 million, respectively, due to lower borrowing levels and interest rates. Nine-month debt extinguishment costs were $6.6 million.
Guidance, Outlook, Risks and Unusual Items
Management did not provide a specific numerical revenue or earnings forecast in the filing. Management expects margins in Packaging and Energy to improve toward historical levels as acquisitions and new branches are integrated and productivity and volume efficiencies develop. Cequent margins are expected to improve as facility consolidation projects become fully operational. Strategic priorities include productivity and cost savings, international and new-product growth, debt reduction and increased liquidity.
- In October 2012, after the reporting date, TriMas amended and restated its credit agreement. The new facilities included a $250 million revolving facility, a $200 million Term Loan A and a $200 million Term Loan B, with maturities extending to 2017 and 2019 and lower stated spreads. The company used the refinancing to repay existing bank debt and repurchase $176.5 million of senior notes; approximately $40 million of cash costs were expected in Q4.
- At September 30, the company had $191.1 million of borrowing capacity for general corporate purposes after leverage restrictions, including $101.7 million under the revolving facility and $89.4 million under the receivables facility. It was in compliance with debt covenants; actual leverage was 2.29x versus a 3.75x limit and interest coverage was 5.08x versus a 2.75x requirement.
- Working-capital investment materially reduced operating cash flow, particularly the $38.8 million increase in receivables and $31.4 million increase in inventory.
- The company is exposed to cyclical demand, consumer sentiment, foreign-exchange movements, raw-material prices, supply disruptions, integration risk, facility-transition costs and variable interest rates. A $100 million interest-rate swap fixes the LIBOR component at 1.80% through June 2016.
- There were 1,119 pending asbestos cases involving 7,972 claimants at September 30, 2012. Management did not believe the cases would materially affect financial position, results or cash flows, but noted potential periods of uninsured defense and indemnity costs.
- On October 18, 2012, management announced a preliminary recommendation to close the Goshen, Indiana manufacturing facility, potentially affecting approximately half of the continuing-operations unionized workforce.
- Other unusual items included a $1.5 million postretirement-plan gain, acquisition-related purchase accounting adjustments, facility relocation costs and a $6.6 million debt-extinguishment charge for the nine months.
Important Facts for Investors to Verify
- Whether the October refinancing and senior-note tender materially reduce interest expense, maturities and liquidity constraints.
- The pace at which Packaging, Energy and Cequent margins recover after acquisitions, new-branch launches and facility consolidations.
- Conversion of reported earnings into operating cash flow as receivables and inventory normalize.
- Integration performance and contingent consideration obligations for Arminak, CIFAL, Engetran and Trail Com.
- The financial and operational effects of the proposed Goshen facility closure and related labor matters.
- Future asbestos settlement, defense and insurance costs, including the timing of primary-insurance exhaustion.
- Exposure to raw-material inflation, foreign-currency movements, consumer demand and cyclical industrial and aerospace markets.